North America

The fundraising drought has been particularly challenging for emerging managers, but both LPs and GPs say there is reason to be optimistic.

Venture funds raised $41.6bn worldwide in the first half of this year, down from $60bn in H1 of last year, according to exclusive research by Venture Capital Journal.

Using his tech sales experience, Justin Wexler works with WndrCo co-founder Jeffrey Katzenberg to help portfolio companies seal deals with Fortune 500 companies.

More venture firms are following the lead of buyout firms by creating continuation funds to provide liquidity to LPs in older funds. Here are the pluses and minuses for GPs and LPs considering CVs.

Investors seem to be directing more capital to support existing portfolio companies instead of pursuing new investments, while earlier timing for mega-deals suggests a push to accelerate development to beat competitors.

With extensive experience in enterprise-ready technology, the firm will invest in 25-30 companies across various funding stages that are developing financial service and supply chain products and services.

The new LP-specialist firm, which is targeting $150m for its debut fund, was founded by two friends with a multigenerational connection.

The $60bn fund and Roadrunner Venture Studios are pairing up with America’s Frontier Fund, Crosslink Capital, Khosla Ventures and others to build a robust VC ecosystem rooted in New Mexico.

Fund IV will target Canadian life science companies in both the medtech and biotech sectors.

Planeteer Capital closed its debut fund with anchor investments from an Ivy League university endowment and Mike Schroepfer, former CTO of Meta and a partner at Gigascale Capital, after pitching more than 400 potential LPs.